Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eaton

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2023
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactionsMark Edward Jao, Amy Ly Indorf, Eve-Michelle Segal, et al.
Oncology|January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancerHendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
BMJ Open|November 3, 2019
Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, CanadaAndrew David Eaton, Sharon L Walmsley, Shelley L Craig, et al.
The British Journal of Radiology|August 24, 2022
Implementation of a comprehensive set of optimised CBCT protocols and validation through imaging quality and dose auditMarina Khan, Navneet Sandhu, Marium Naeem, et al.
The British Journal of Radiology|August 23, 2019
Guidance on the use of PET for treatment planning in radiotherapy clinical trialsLucy C Pike, Christopher M Thomas, Teresa Guerrero-Urbano, et al.
The British Journal of Radiology|June 2, 2016
Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructureSarah Gwynne, Gareth Jones, Rhydian Maggs, et al.
Physics and Imaging in Radiation Oncology|September 19, 2024
Autocontouring of primary lung lesions and nodal disease for radiotherapy based only on computed tomography imagesStephen Skett, Tina Patel, Didier Duprez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trialIndrani S Bhattacharya, Joanne S Haviland, Carola Perotti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2023
Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic reviewNicholas Hardcastle, Mirjana Josipovic, Enrico Clementel, et al.
BMJ Open|April 19, 2018
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancerJohn Conibear, Brendan Chia, Yenting Ngai, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2023
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactionsMark Edward Jao, Amy Ly Indorf, Eve-Michelle Segal, et al.
Oncology|January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancerHendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
BMJ Open|November 3, 2019
Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, CanadaAndrew David Eaton, Sharon L Walmsley, Shelley L Craig, et al.
The British Journal of Radiology|August 24, 2022
Implementation of a comprehensive set of optimised CBCT protocols and validation through imaging quality and dose auditMarina Khan, Navneet Sandhu, Marium Naeem, et al.
The British Journal of Radiology|August 23, 2019
Guidance on the use of PET for treatment planning in radiotherapy clinical trialsLucy C Pike, Christopher M Thomas, Teresa Guerrero-Urbano, et al.
The British Journal of Radiology|June 2, 2016
Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructureSarah Gwynne, Gareth Jones, Rhydian Maggs, et al.
Physics and Imaging in Radiation Oncology|September 19, 2024
Autocontouring of primary lung lesions and nodal disease for radiotherapy based only on computed tomography imagesStephen Skett, Tina Patel, Didier Duprez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trialIndrani S Bhattacharya, Joanne S Haviland, Carola Perotti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2023
Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic reviewNicholas Hardcastle, Mirjana Josipovic, Enrico Clementel, et al.
BMJ Open|April 19, 2018
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancerJohn Conibear, Brendan Chia, Yenting Ngai, et al.
Pageof 3